Gail Cawkwell

Gail Cawkwell

Former Chief Medical OfficeratAclaris Therapeutics· In proxies 2022–2023

Pay in FY2022Aclaris Therapeutics stock +8.3% the same year

Gail Cawkwell was paid $3.3M in FY2022 (Dec). Aclaris Therapeutics stock rose 8.3% that year.

Pay$100 in the stock at the end of FY21 → $108
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -74%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?